January 16, 2024. T-CURX will present at Advanced Therapies Week in Miami-Beach, FL

Leadership Team members will present an update on T-CURX CAR-T development activities at Phacilitate's U.S. flagship event, the Advanced Therapies Week from Jan 16-19, 2024 in Miami Beach, FL, U.S.A.

A team of three members of T-CURX leadership team and Board of Directors, including the company's CEO, Ulf Grawunder, PhD, it's Head Preclinical Development, Jan Van den Brulle, PhD, and T-CURX independent Board member, Bernd Eschgfäller, PhD, will attend the 2024 Advanced Therapies Week (https://advancedtherapiesweek....) at Miami Beach Convention Center, Miami Beach, FL.

The Advanced Therapies Week at the beginning of the year is Phacilitate's flagship event in the U.S., entirely focusing on the field of Cell and Gene Therapy. More than 2'500 attendees from more than 600 Biotech companies, 180 exhibitors, 100 investors and 250 speakers from the industry are expected to attend this year's event.

T-CURX CEO, Ulf Grawunder, will present an update on the company's CAR-T development activities, including technology development and CAR-T pipeline products. His presentation will take place during the "Innovation Stage" on Thursday, Jan 18, from 4-5 p.m. Ulf will also participate in a panel discussion on "Investing in Europe in Cell and Gene Therapy" taking place on Friday, Jan 19, from 11:30 a.m. to 12:30 p.m.

T-CURX Board member, Bernd Eschgfäller, will participate in a panel discussion on "International Supply Chains - Crossing Borders and Breaking Barriers" taking place on Wednesday, Jan 17, from 4-5 p.m.